pbs tirzepatide Pharmaceutical giants Eli Lilly, Novo Nordisk push for weight-loss drugs Mounjaro and Ozempic to be added to InVivoSIM GIPR/GLP‑1R Dual Agonist (Tirzepatide

A total of 16% of the 1049 patients had taken silymarin in the past, with an average treatment lasting 6 months, and 16% had been taking it at the time of the baseline examination for an average of 35 months

The FDA prescribing information includes a boxed warning about thyroid C-cell tumors observed in animal studies, though relevance to humans remains uncertain

Thailand Slim focuses on physician-supervised information and consultation pathways so eligible patients can better understand their options in a responsible and medically appropriate way

All case series and reports 151,152,153,154,155 reported better metabolic outcomes in patients with comorbid severe mental illness and diabetes and/or obesity who were concomitantly treated with antipsychotics and GLP-1RAs